Concepedia

Clinical Validation of the Abbott RealTi <i>m</i> e High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening

Albertus T. Hesselink, Chris J.L.M. Meijer, Mario Poljak, Johannes Berkhof, Folkert J. van Kemenade, M. L. van der Salm, Martijn Bogaarts, Peter J.F. Snijders, Daniëlle A.M. Heideman

Journal of Clinical Microbiology · 2013 · 49 citations · 8 references

DOIFull text

Open access

Concepts

Abstract

This study showed that the Abbott RealTime High Risk HPV assay fulfilled cross-sectional clinical equivalence and reproducibility criteria of international consensus guidelines, which indicates that this assay can be considered clinically validated for cervical cancer screening purposes.

References

8

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

Chris J.L.M. Meijer, Johannes Berkhof, Philip E. Castle et al. · International Journal of Cancer · 2008 · 695 citations · Full text

, , +17

Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes

Daniëlle A.M. Heideman, Albertus T. Hesselink, Johannes Berkhof et al. · Journal of Clinical Microbiology · 2011 · 216 citations · Full text

, , +16

Congenital cytomegalovirus: Public health action towards awareness, prevention, and treatment

Gail J. Demmler‐Harrison · Journal of Clinical Virology · 2009 · 79 citations

, , +14

Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening

Mario Poljak, Anja Oštrbenk, Katja Seme et al. · Journal of Clinical Microbiology · 2011 · 74 citations · Full text

, , +17

Validation of high-risk HPV tests for primary cervical screening

Chris J.L.M. Meijer, Daniëlle A.M. Heideman, Albertus T. Hesselink et al. · Journal of Clinical Virology · 2009 · 71 citations

, , +14